{"id":"AGY-FED-HEALTH-OTHER-011","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","authority":"21 C.F.R. 1307.03; exception to 21 C.F.R. 1301.12 (separate registration in each State)","instrument":"DEA-DC-018 (DEA067), Dear Registrant letter granting an exception to separate State registration for practitioners dispensing in additional States during the COVID-19 emergency","title":"DEA State Reciprocity (final) (Signed)","dateIssued":"2020-03-25","effective":"2020-03-25","end":"For the duration of the public health emergency declared Jan. 31, 2020","startDate":"2020-03-25","endDate":"","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"addressees":["DEA registrants (practitioners)"],"clause":"in view of the extraordinary circumstances that have arisen during this public health emergency, and in order to ensure adequate medical care for the duration of this public health emergency, DEA will grant an exception for practitioners in such states to those provisions of DEA regulations that normally require practitioners to register in each state where they dispense controlled substances.... DEA-registered practitioners are not required to obtain additional registration(s) with DEA in the additional state(s) where the dispensing (including prescribing and administering) occurs, for the duration of the public health emergency declared on January 31, 2020, if authorized to dispense controlled substances by both the state in which a practitioner is registered with DEA and the state in which the dispensing occurs.","enforcement":"Exception to registration requirements otherwise enforceable under 21 U.S.C. 841-843","functions":["TM telehealth across State lines","HR credentialing and travel practitioners","CL clinical"],"notes":"Predicate for travel nurses and physicians, telehealth companies and multi-State practices operating under State licensure waivers.","sourceUrl":"https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-018)(DEA067)%20DEA%20state%20reciprocity%20(final)(Signed).pdf","snapshot":"","fileExists":true,"fileBytes":183336,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-011","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-011","citation":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA, DEA-DC-018 (DEA067), Dear Registrant letter granting an exception to separate State registration for practitioners dispensing in additional States during the COVID-19 emergency (Mar. 25, 2020) (Ex. AGY-FED-HEALTH-OTHER-011)","stateName":"","related":["AGY-FED-HEALTH-OTHER-010","AGY-FED-HEALTH-OTHER-014","AGY-FED-HEALTH-OTHER-016","AGY-FED-HEALTH-OTHER-020"]}